Clinical Trial Update: Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating rapid-acting intramuscular olanzapine in Japanese patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Zyprexa (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: COMPLETED